Literature DB >> 17576211

Mutations of chronic granulomatous disease in Turkish families.

M Y Köker1, O Sanal, M De Boer, I Tezcan, A Metin, F Ersoy, D Roos.   

Abstract

BACKGROUND: Chronic granulomatous disease (CGD) is an inherited disorder of the innate immune system characterized by impairment of intracellular microbicidal activity of phagocytes. Mutations in one of four known NADPH-oxidase components preclude generation of superoxide and related antimicrobial oxidants, leading to the phenotype of CGD. Defects in gp91-phox, encoded by CYBB, lead to X-linked CGD and have been reported to be responsible for approximately 70% of all CGD cases. The aim of this study was to identify the CGD mutations in a group of Turkish CGD patients and to evaluate the predominance of CGD mutations as X-linked or autosomal recessive (AR) within the Turkish CGD families with known mutations.
MATERIALS AND METHODS: Two Turkish CGD families were included in the study, and mutations were identified by sequence analysis of DNA and RNA from peripheral blood in the patients. Before mutation analysis, subgroup analysis of patients was made by flow cytometry with antibodies against NADPH oxidase components and with DHR-123 oxidase activity assay. For comparison, we included previously reported results from four other Turkish CGD families.
RESULTS: Two different mutations were identified, one of them a novel mutation g.700G>T located in exon 7 of CYBB, and the other a hot-spot mutation located in exon 2 of the NCF1 gene. These mutations were detected in three patients from two Turkish families.
CONCLUSIONS: Until now, we have altogether identified mutations in six Turkish CGD families. In this limited number of families our results show AR-CGD in two-thirds of the Turkish families investigated, in contrast to previous reports in the literature. This is probably due to the high rate of consanguineous marriages in Turkey. Consanguineous parents were found in 75% of the families with AR-CGD patients, which favours homozygous deficiencies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576211     DOI: 10.1111/j.1365-2362.2007.01828.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

Review 2.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

3.  Successful unrelated donor cord blood transplantation for chronic granulomatous disease.

Authors:  Tang-Her Jaing; Wen I Lee; Po-Jen Cheng; Shih-Hsiang Chen; Jing-Long Huang; Yung-Kuei Soong
Journal:  Int J Hematol       Date:  2010-03-12       Impact factor: 2.490

4.  Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting.

Authors:  Harry R Hill; Nancy H Augustine; Robert J Pryor; Gudrun H Reed; Joshua D Bagnato; Anne E Tebo; Jeffrey M Bender; Brian M Pasi; Javier Chinen; I Celine Hanson; Martin de Boer; Dirk Roos; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2010-03-12       Impact factor: 5.568

5.  Molecular basis of autosomal recessive chronic granulomatous disease in iran.

Authors:  Shahram Teimourian; Martin de Boer; Dirk Roos
Journal:  J Clin Immunol       Date:  2010-04-21       Impact factor: 8.317

6.  Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease.

Authors:  Fatemeh Fattahi; Mohsen Badalzadeh; Leyla Sedighipour; Masoud Movahedi; Mohammad Reza Fazlollahi; Seyed Davood Mansouri; Ghamar Taj Khotaei; Mohammad Hassan Bemanian; Fatemeh Behmanesh; Amir Ali Hamidieh; Nasrin Bazargan; Setareh Mamishi; Fariborz Zandieh; Zahra Chavoshzadeh; Iraj Mohammadzadeh; Seyed Alireza Mahdaviani; Seyed Ahmad Tabatabaei; Najmeddin Kalantari; Shaghayegh Tajik; Marzieh Maddah; Zahra Pourpak; Mostafa Moin
Journal:  J Clin Immunol       Date:  2011-07-26       Impact factor: 8.317

Review 7.  Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Jacinta Bustamante; Caroline Kannengiesser; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Baruch Wolach; Joachim Roesler; Harry L Malech; Steven M Holland; John I Gallin; Marie-José Stasia
Journal:  Blood Cells Mol Dis       Date:  2010-02-18       Impact factor: 3.039

8.  A highly sensitive chemiluminescence assay for superoxide detection and chronic granulomatous disease diagnosis.

Authors:  Tsuyoshi Yamazaki; Chikage Kawai; Akira Yamauchi; Futoshi Kuribayashi
Journal:  Trop Med Health       Date:  2011-06-14

Review 9.  Considerations in the Diagnosis of Chronic Granulomatous Disease.

Authors:  Joyce E Yu; Antoine E Azar; Hey J Chong; Artemio M Jongco; Benjamin T Prince
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.